Stigma and Inaccessibility are Limiting Opioid Treatment Effectiveness
Experts say stigma regarding treatment options and limited access to resources is hindering opioid recovery.
Drugs & Medical Devices
Pfizer Given Rights to AnTolRx’s Therapies for Type 1 Diabetes
Private biotechnology company AnTolRx has announced Pfizer has exercised the option to license an immune tolerance therapy related to Type 1 diabetes.
CDC Documents Third Wave in Opioid Crisis Centered Around Fentanyl
The third wave of the nation’s opioid crisis involves increased fentanyl use, reports the CDC.
Purdue and Sacklers Settle Oklahoma Opioid Case for $270 Million
Purdue Pharma and the Sackler family have reached a settlement with the state of Oklahoma. Two other defendants remain, Johnson & Johnson and Teva Pharmaceuticals.
Senator’s Misguided Tweet Fuels Social Media Opioid Debate
Senator Kirsten Gillibrand (D-NY) recently tweeted that overprescribing of opioids is the root cause of the epidemic and her post was met with strong opposition.
Study Suggests High Michigan Suicide Rate Linked to Opioid Overdoses
Suicide rates in Michigan are alarmingly high and may be linked to opioid use, according to a recent University of Michigan study.
Alcohol is a Risky, Yet Effective Pain Management Option
Researchers have found that alcohol is an effective, yet risky way to manage pain.
Minority Patients More Likely to Receive Opioids, Reveals California Study
California study suggests that minority patients are more likely to be prescribed addictive opioid painkillers than non-minorities.
Will Purdue Declare Chapter 11 Bankruptcy Amid Opioid Litigation?
Rumor has it that Purdue is planning to file Chapter 11 bankruptcy to halt the 2,000 lawsuits against it for deceptively marketing OxyContin to doctors and patients.
After Delays, Awerbuch Will Finally Start Serving Prison Term
Dr. Gavin Awerbuch is set to start serving time in prison this April for drug charges and health care fraud.